Hedge Fund - EcoR1 Capital
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $23.46 |
| 2 | 2025 - Q3 (2025-09-30) | $78,009,140 | 3.74% | 3,447,156 | $23.32 |
| 3 | 2025 - Q2 (2025-06-30) | $205,916,436 | 12.19% | 11,895,808 | $18.51 |
| 4 | 2025 - Q1 (2025-03-31) | $260,161,321 | 15.43% | 11,895,808 | $27.63 |
| 5 | 2024 - Q4 (2024-12-31) | $379,436,800 | 14.34% | 11,890,843 | $30.07 |
| 6 | 2024 - Q3 (2024-09-30) | $342,931,912 | 11.73% | 11,890,843 | $37.03 |
| 7 | 2024 - Q2 (2024-06-30) | $445,260,823 | 13.62% | 11,607,425 | $45.29 |
| 8 | 2024 - Q1 (2024-03-31) | $667,589,442 | 16.88% | 11,357,425 | $63.75 |
| 9 | 2023 - Q4 (2023-12-31) | $668,819,850 | 17.36% | 11,173,068 | $50.73 |
| 10 | 2023 - Q3 (2023-09-30) | $414,630,636 | 13.98% | 10,899,859 | $43.93 |
| 11 | 2023 - Q2 (2023-06-30) | $496,645,042 | 12.16% | 5,451,647 | $86.28 |
| 12 | 2023 - Q1 (2023-03-31) | $359,590,636 | 11.57% | 5,451,647 | $57.70 |
| 13 | 2022 - Q4 (2022-12-31) | $268,035,217 | 8.15% | 5,183,431 | $53.04 |
| 14 | 2022 - Q3 (2022-09-30) | $354,028,000 | 10.44% | 5,183,431 | $59.17 |
| 15 | 2022 - Q2 (2022-06-30) | $234,395,000 | 8.09% | 5,183,431 | $45.59 |
| 16 | 2022 - Q1 (2022-03-31) | $263,370,000 | 8.23% | 5,183,431 | $44.15 |
| 17 | 2021 - Q4 (2021-12-31) | $190,722,000 | 6.07% | 4,033,882 | $39.37 |
| 18 | 2018 - Q2 (2018-06-30) | $0 | 0% | 0 | $22.98 |
| 19 | 2018 - Q1 (2018-03-31) | $23,356,000 | 2.34% | 1,056,348 | $19.65 |
| 20 | 2017 - Q4 (2017-12-31) | $24,837,000 | 2.79% | 1,144,558 | $14.72 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center